Our broad portfolio consists of multiplex panels that allow you to choose, within the panel, analytes that best meet your needs. On a separate tab you can choose the premixed cytokine format or a single plex kit.
Cell Signaling Kits & MAPmates™
Choose fixed kits that allow you to explore entire pathways or processes. Or design your own kits by choosing single plex MAPmates™, following the provided guidelines.
The following MAPmates™ should not be plexed together:
-MAPmates™ that require a different assay buffer
-Phospho-specific and total MAPmate™ pairs, e.g. total GSK3β and GSK3β (Ser 9)
-PanTyr and site-specific MAPmates™, e.g. Phospho-EGF Receptor and phospho-STAT1 (Tyr701)
-More than 1 phospho-MAPmate™ for a single target (Akt, STAT3)
-GAPDH and β-Tubulin cannot be plexed with kits or MAPmates™ containing panTyr
.
Catalogue Number
Ordering Description
Qty/Pack
List
This item has been added to favorites.
Select A Species, Panel Type, Kit or Sample Type
To begin designing your MILLIPLEX® MAP kit select a species, a panel type or kit of interest.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
This item has been added to favorites.
Species
Panel Type
Selected Kit
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
96-Well Plate
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
Add Additional Reagents (Buffer and Detection Kit is required for use with MAPmates)
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Space Saver Option Customers purchasing multiple kits may choose to save storage space by eliminating the kit packaging and receiving their multiplex assay components in plastic bags for more compact storage.
This item has been added to favorites.
The Product Has Been Added To Your Cart
You can now customize another kit, choose a premixed kit, check out or close the ordering tool.
Emprove® Evolve For Raw Materials: Used in Early Stages of Biopharmaceutical Manufacturing. The new Emprove® Evolve product line provides fit-for-purpose high-quality raw materials addressing applications in early stages of pharmaceutical and biopharmaceutical manufacturing such as: upstream processing, early downstream processing, clean-in-place, early synthetic steps in small molecule drug manufacture.
Emprove® Dossiers for Chemicals: Satisfy Your Regulatory Requirements. Three Levels of Information Supporting Quality Risk Assessment and Regulatory Requirements To address evolving regulatory requirements, we are constantly developing our Emprove® Dossier library to better meet your regulatory challenges. The information on each of our Emprove® Evolve, Emprove® Essential and Emprove® Expert products facilitates your raw material qualification, risk assessment and process optimization efforts.
Explore our Bioprocess 4.0 booth to learn how our latest products, services and software can help you achieve great leaps in productivity as we converge, intensify and evolve together towards Bioprocessing 4.0.
Emprove® Chemicals Portfolio: Starting and Raw Materials. Satisfy Your Regulatory Requirements. Our Emprove® Chemicals portfolio contains over 400 pharmaceutical raw materials. To address different levels of risk, and to simplify and streamline the selection process, the portfolio is divided into four categories: Emprove® Evolve, Emprove® Essential, Emprove® Expert and Emprove® API.
Increasing levels of transparency filtration and single-use components. Confidence with your product development. As the biopharmaceutical industry evolves, it also shapes the need for higher transparency along the supply chain and standardization. Information is crucial for manufacturers when selecting filtration and single-use technologies and other materials.
Emprove® Dossiers for Purification in Biomanufacturing Process High performing resins meet regulatory excellence Any component and raw material used at a later stage of the biomanufacturing process is considered a risk, as it could add a bioburden to the final drug product. While being essential, chromatography steps are often a challenge as they are highly process specific and might be present from early to late downstream. Therefore, information is crucial for manufacturers when selecting chromatography methods and products.
Ease your regulatory efforts with Emprove® dossiers for Cell Culture Media for Upstream Processes. Cell culture media (CCM) have a critical role in manufacturing as they drive the productivity of upstream processes and help ensure critical quality attributes of the final drug product. Therefore it is recommended that media be included in drug product risk assessments.